Skip to main content

Table 2 Demographic characters and related risk factors of persons based on all stages of CKD

From: Associations between dietary patterns and stages of chronic kidney disease

Characteristics

Overall

Mean ± SD(%)

Stage 1

Stage 2

Stage 3a

Stage 3b

Stage 4

Stage 5

p-value

Sex

Male (%)

42.07

39.51

47.99

43.54

35.70

31.04

50.53

 < 0.001

Female (%)

57.93

60.49

52.01

56.46

64.30

68.96

49.47

Age (Years), [mean (95% CI)]

60.0

(59.5–60.5)

42.1

(41.3–42.9)

63.3

(62.4–64.2)

69.3

(68.7–69.9)

73.9

(73.2–74.6)

72.5

(70.8–74.1)

60.2

(56.8–63.5)

 < 0.001

Race/Ethnicity

Mexican American (%)

7.24

14.48

5.35

2.71

3.66

6.71

7.24

 < 0.001

Other Hispanic (%)

4.72

7.85

4.23

2.60

3.45

3.25

4.36

White (non-Hispanic) (%)

70.01

53.09

72.58

82.95

79.22

67.39

44.15

Non-Hispanic Black (%)

12.04

16.09

11.23

8.03

9.57

16.65

36.47

Other (%)

5.99

8.49

6.62

3.72

4.10

6.01

7.78

BMI (kg/m2)

29.94 ± 0.11

30.04 ± 0.23

30.18 ± 0.25

29.56 ± 0.18

30.35 ± 0.34

30.46 ± 0.54

28.58 ± 0.84

0.128

Waist circumference (cm)

102.90 ± 0.27

100.81 ± 0.56

104.67 ± 0.58

103.19 ± 0.43

104.9 ± 0.72

105.45 ± 1.21

99.83 ± 2.16

 < 0.001

Triglycerides (mg/dL)

141.50 ± 2.57

146.71 ± 5.7

147.03 ± 4.44

133.68 ± 3.25

142.59 ± 6.53

166.97 ± 12.23

115.35 ± 9.22

0.063

Total cholesterol (mg/dL)

192.60 ± 0.69

198.25 ± 1.28

192.86 ± 1.42

192.32 ± 1.23

181.91 ± 1.91

179.77 ± 3.31

181.17 ± 5.64

 < 0.001

High density lipoprotein

52.92 ± 0.27

52.85 ± 0.55

52.99 ± 0.56

53.97 ± 0.45

50.79 ± 0.69

49.8 ± 1.23

52.65 ± 1.91

0.007

Serum triglycerides/HDL cholesterol ratio

3.28 ± 0.10

3.65 ± 0.23

3.27 ± 0.14

2.91 ± 0.11

3.26 ± 0.21

4.08 ± 0.39

2.41 ± 0.31

0.016

Apolipoprotein (B) (mg/dL)

92.20 ± 0.61

94.44 ± 1.07

94.1 ± 1.15

89.68 ± 1.07

89.15 ± 1.94

89.86 ± 2.64

79.88 ± 4.45

 < 0.001

Systolic blood pressure (mmHg)

130.80 ± 0.33

125.82 ± 0.57

135.37 ± 0.73

131.09 ± 0.55

132.89 ± 1

137.13 ± 2.07

135.84 ± 3.57

 < 0.001

Diastolic blood pressure (mmHg)

68.15 ± 0.23

72.82 ± 0.39

70.06 ± 0.51

65.72 ± 0.38

61.16 ± 0.68

58.67 ± 1.41

66.62 ± 1.75

 < 0.001

Fasting blood glucose (mg/dL)

120.90 ± 1.12

121.08 ± 2.1

129.95 ± 2.68

115.65 ± 1.37

123.06 ± 3.16

126.82 ± 5.68

114.69 ± 6.27

 < 0.001

Plasma Insulin (uU/mL)

15.68 ± 0.60

16.6 ± 1.08

16.56 ± 0.91

14.75 ± 0.68

19.67 ± 3.46

16.2 ± 2.29

6.41 ± 0.7

0.095

HOMA-IR

5.28 ± 0.26

5.55 ± 0.43

5.71 ± 0.41

4.98 ± 0.38

7.02 ± 1.43

5.37 ± 0.8

1.77 ± 0.23

0.152

HbA1c (%)

6.14 ± 0.02

6.1 ± 0.05

6.26 ± 0.05

6.03 ± 0.03

6.28 ± 0.05

6.37 ± 0.09

6.13 ± 0.17

 < 0.001

2-h blood glucose (mg/dL)

138.6 ± 1.83

130.3 ± 3.4

147.4 ± 4.0

139.49 ± 2.7

149.75 ± 5.3

166.3 ± 11.9

160.3 ± 16.1

 < 0.001

Hypertension (%)

58.07

35.48

61.99

65.34

82.60

86.23

84.28

 < 0.001

Diabetes (%)

25.16

18.17

28.80

22.68

36.15

46.43

51.48

 < 0.001

Metabolic syndrome (%)

39.14

31.25

42.06

38.60

51.69

61.60

34.81

 < 0.001

Dietary pattern 1 [saturated fatty acids & MUFA] (%)

High intake

27.68

31.55

27.12

25.89

25.17

18.98

28.16

 < 0.001

Middle-to-high intake

26.26

26.98

26.32

26.55

26.36

20.84

11.75

 

Low-to-middle intake

23.67

20.67

21.56

26.60

24.84

33.95

24.60

 

Low intake

22.39

20.80

25.00

20.95

23.63

26.23

35.50

 

Dietary pattern 2 [vitamins & minerals] (%)

High intake

27.58

28.78

31.57

26.70

22.51

21.18

11.48

 < 0.001

Middle-to-high intake

24.58

24.20

24.89

25.01

23.90

27.85

15.78

 

Low-to-middle intake

24.41

26.37

20.35

25.24

25.38

21.71

20.31

 

Low intake

23.43

20.65

23.18

23.05

28.21

29.27

52.43

 

Dietary pattern 3 [cholesterols & PUFA] (%)

High intake

23.27

27.54

25.18

21.85

15.57

11.45

15.32

 < 0.001

Middle-to-high intake

24.72

27.24

20.98

25.26

24.51

20.42

23.07

 

Low-to-middle intake

26.39

23.90

26.29

27.51

27.42

30.94

42.81

 

Low intake

25.63

21.32

27.55

25.39

32.51

37.20

18.80

 
  1. CKD chronic kidney diseases, SD standard deviation, CI confidence interval, BMI Body mass index, HDL high density lipoprotein, HOMA-IR homeostatic model assessment of insulin resistance, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids